Proton linear energy transfer and variable relative biological effectiveness for adolescent patients with Hodgkin lymphoma.
Journal
BJR open
ISSN: 2513-9878
Titre abrégé: BJR Open
Pays: England
ID NLM: 101749810
Informations de publication
Date de publication:
2023
2023
Historique:
received:
23
01
2023
accepted:
24
01
2023
medline:
11
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
epublish
Résumé
Proton therapy has a theoretical dosimetric advantage due to the Bragg peak, but the linear energy transfer (LET), and therefore the relative biological effectiveness (RBE), increase at the end of range. For patients with Hodgkin lymphoma, the distal edge of beam is often located within or close to the heart, where elevated RBE would be of potential concern. The purpose of this study was to investigate the impact of RBE and the choice of beam arrangement for adolescent patients with mediastinal Hodgkin lymphoma. For three previously treated adolescent patients, proton plans with 1-3 fields were created to a prescribed dose of 19.8 Gy (RBE) in 11 fractions (Varian Eclipse v13.7), assuming an RBE of 1.1. Plans were recalculated using Monte-Carlo (Geant4 v10.3.3/Gate v8.1) to calculate dose-averaged LET. Variable RBE-weighted dose was calculated using the McNamara model, assuming an α/β ratio of 2 Gy for organs-at-risk. Although the LET decreased as the number of fields increased, the difference in RBE-weighted dose (Δdose) to organs-at-risk did not consistently decrease. Δdose values varied by patient and organ and were mostly of the order of 0-3 Gy (RBE), with a worst-case of 4.75 Gy (RBE) in near-maximum dose to the left atrium for one plan. RBE-weighted doses to organs-at-risk are sensitive to the choice of RBE model, which is of particular concern for the heart. There is a need to remain cautious when evaluating proton plans for Hodgkin lymphoma, especially when near-maximum doses to organs-at-risk are considered.
Identifiants
pubmed: 37035769
doi: 10.1259/bjro.20230012
pmc: PMC10077416
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20230012Informations de copyright
© 2023 The Authors. Published by the British Institute of Radiology.
Références
Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1097-1106
pubmed: 27869082
Phys Med Biol. 2017 Dec 19;63(1):015013
pubmed: 29131808
Phys Med Biol. 2009 Jul 21;54(14):4399-421
pubmed: 19550004
Radiat Prot Dosimetry. 2012 Apr;149(2):116-23
pubmed: 21593038
Radiat Oncol. 2018 Mar 27;13(1):56
pubmed: 29587881
Radiat Oncol. 2016 May 17;11:68
pubmed: 27185038
Phys Med Biol. 2005 Jun 21;50(12):2765-77
pubmed: 15930601
Med Phys. 2014 Jun;41(6):064301
pubmed: 24877844
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):747-757
pubmed: 30395906
Acta Oncol. 2017 Jun;56(6):769-778
pubmed: 28464736
J Natl Cancer Inst. 2015 Feb 23;107(4):
pubmed: 25713164
Acta Oncol. 2015 Jan;54(1):60-6
pubmed: 25025999
Radiother Oncol. 2017 Mar;122(3):416-422
pubmed: 28233564
Blood. 2002 Sep 15;100(6):1989-96
pubmed: 12200357
Phys Med Biol. 2018 Sep 13;63(18):185013
pubmed: 30102240
Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1057-64
pubmed: 25832696
Blood. 2018 Oct 18;132(16):1635-1646
pubmed: 30108066
Radiat Oncol. 2019 Dec 30;14(1):243
pubmed: 31888769
Med Phys. 2013 Jan;40(1):011705
pubmed: 23298075
Biomed Phys Eng Express. 2021 Dec 17;8(1):
pubmed: 34874308
Cancer J. 2009 Jul-Aug;15(4):298-305
pubmed: 19672146
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):287-296
pubmed: 26691786
Phys Med Biol. 2015 Jul 21;60(14):N283-91
pubmed: 26147442
Int J Radiat Biol. 2007 Jan;83(1):27-39
pubmed: 17357437
Acta Oncol. 2013 Apr;52(3):580-8
pubmed: 22909391
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85
pubmed: 20171522
Med Phys. 2019 Mar;46(3):e53-e78
pubmed: 30661238
Acta Oncol. 2017 Jun;56(6):763-768
pubmed: 28423966
Phys Med Biol. 2014 Nov 21;59(22):R419-72
pubmed: 25361443
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):854-62
pubmed: 23790512
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1559-66
pubmed: 21163588
Radiother Oncol. 2017 Oct;125(1):41-47
pubmed: 28838605
Radiother Oncol. 2016 Dec;121(3):395-401
pubmed: 27863964
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):809-819
pubmed: 29976493
Adv Radiat Oncol. 2018 Dec 13;4(1):156-167
pubmed: 30706024
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):824-9
pubmed: 12377335
Int J Radiat Oncol Biol Phys. 1985 Jan;11(1):87-96
pubmed: 3881377
Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):401-410
pubmed: 27986346
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):407-21
pubmed: 12023146
Phys Med Biol. 2015 Nov 7;60(21):8399-416
pubmed: 26459756
Phys Med Biol. 2006 Jul 7;51(13):R491-504
pubmed: 16790919
J Natl Cancer Inst. 2002 Feb 6;94(3):182-92
pubmed: 11830608
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):216-22
pubmed: 23790771
Med Phys. 2020 Aug;47(8):3675-3681
pubmed: 32422684
Radiother Oncol. 2020 Nov;152:216-221
pubmed: 32663535
Phys Med Biol. 2013 Apr 7;58(7):2103-17
pubmed: 23470339
Radiat Res. 2015 Feb;183(2):174-87
pubmed: 25587741
J Clin Oncol. 2016 Jan 20;34(3):235-43
pubmed: 26573075
Phys Med Biol. 2015 Apr 21;60(8):R155-209
pubmed: 25803097
Radiother Oncol. 1999 Feb;50(2):135-42
pubmed: 10368035
Phys Med Biol. 2004 Jul 7;49(13):2811-25
pubmed: 15285249
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):454-464
pubmed: 27084660
Br J Radiol. 2020 Oct 01;93(1114):20200228
pubmed: 32726141
Acta Oncol. 2019 Jan;58(1):95-104
pubmed: 30280626
Med Phys. 2017 Mar;44(3):810-822
pubmed: 28107554
Lancet Haematol. 2015 Nov;2(11):e492-502
pubmed: 26686259
J Thorac Oncol. 2023 Jan;18(1):57-66
pubmed: 36130693
Haematologica. 2010 Mar;95(3):494-500
pubmed: 19951972